BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8050082)

  • 1. Assessing benefits of combining biochemical and immunological markers in patients with lung carcinoma.
    Patel PS; Raval GN; Rawal RR; Patel GH; Balar DB; Shah PM; Patel DD
    Cancer Lett; 1994 Jul; 82(2):129-33. PubMed ID: 8050082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
    Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
    Patel PS; Raval GN; Rawal RM; Patel GH; Balar DB; Shah PM; Patel DD
    Neoplasma; 1995; 42(5):271-4. PubMed ID: 8552208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
    Zhu X
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
    Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum sialic acid and carcinoembryonic antigen for the detection of early-stage colorectal cancer.
    Tautu C; Pee D; Dunsmore M; Prorok JJ; Alhadeff JA
    J Clin Lab Anal; 1991; 5(4):247-54. PubMed ID: 1890538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sialic acid and carcinoembryonic levels in the detection and monitoring of colorectal cancer.
    Verazin G; Riley WM; Gregory J; Tautu C; Prorok JJ; Alhadeff JA
    Dis Colon Rectum; 1990 Feb; 33(2):139-42. PubMed ID: 2298100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer.
    Gail MH; Muenz L; McIntire KR; Radovich B; Braunstein G; Brown PR; Deftos L; Dnistrian A; Dunsmore M; Elashoff R
    J Natl Cancer Inst; 1986 May; 76(5):805-16. PubMed ID: 2422426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total and lipid-bound serum sialic acid as markers for carcinoma of the uterine cervix.
    Vivas I; Spagnuolo L; Palacios P
    Gynecol Oncol; 1992 Aug; 46(2):157-62. PubMed ID: 1500016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipid-bound sialic acid alterations in neoplastic diseases.
    Dwivedi C; Dixit M; Hardy RE
    Experientia; 1990 Jan; 46(1):91-4. PubMed ID: 2298288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple markers for lung cancer diagnosis: validation of models for localized lung cancer.
    Gail MH; Muenz L; McIntire KR; Radovich B; Braunstein G; Brown PR; Deftos L; Dnistrian A; Dunsmore M; Elashoff R
    J Natl Cancer Inst; 1988 Mar; 80(2):97-101. PubMed ID: 3343691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
    López Sáez JJ; Senra-Varela A
    Int J Biol Markers; 1995; 10(3):174-9. PubMed ID: 8551061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid bound sialic acid in cancer patients.
    Salvagno L; Ferrazzi E; Sileni VC; Maggi S; Tredese F; Bedendo C; Russo MP; Fiorentino MV; Ceriotti G
    Tumori; 1985 Apr; 71(2):127-33. PubMed ID: 4002346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of serum sialoglycoproteins in patients with lung cancer.
    Patel PS; Baxi BR; Balar DB
    Neoplasma; 1989; 36(1):53-9. PubMed ID: 2539569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients.
    Patel PS; Rawal GN; Balar DB
    Gynecol Oncol; 1993 Sep; 50(3):294-9. PubMed ID: 8406190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of determining lipid-bound sialic acid for the diagnosis and further prognosis of cancer.
    Polívková J; Vosmiková K; Horák L
    Neoplasma; 1992; 39(4):233-6. PubMed ID: 1436234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
    Dabrowska B; Krasnodebski IW; Tadeusiak W
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker.
    Laganà A; Pardo-Martínez B; Marino A; Fago G; Bizzarri M
    Clin Chim Acta; 1995 Dec; 243(2):165-79. PubMed ID: 8747492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sialic acid and alkaline DNase in breast cancer.
    Raval GN; Parekh LJ; Patel MM; Patel PS; Rawal RM; Balar DB; Patel DD
    Int J Biol Markers; 1997; 12(2):61-7. PubMed ID: 9342634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.